Stock Market Today: Dow Ends Lower as Post-Fed Stumble Continues

By Yasin Ebrahim

Investing.com -- The Dow cut some losses Thursday, but remained firmly in the red as growth sectors of the market including consumer and tech stocks floundered on fears that the Federal Reserve’s increasingly hawkish stance could tip the economy into recession.

The Dow Jones Industrial Average slipped 0.3%, or 107 points, the Nasdaq was down 1.4%, and the S&P 500 fell 0.9%.

The Fed’s 0.75% rate hike on Wednesday was largely expected, but its updated forecasts, pointing to further rate hikes, raise the risk of recession.

“The higher the peak the Fed aims for, the greater the risk of recession,” Morgan Stanley said in a note. A material slowdown in job gains, however, could persuade the Fed to “take pressure off the pace of policy tightening,” it added.

The bond market appears to price in the increasing risk of a recession amid deeper inversions in the yield curve. The curve between the 2-year and 10-year Treasury yields further inverted to levels not seen since 1982.

Growth sectors of the market -- typically include higher-valued stocks and are vulnerable to a rising rate environment – such as tech and consumer stocks led the broader market lower.

But the move lower in big tech, however, appeared to attract dip-buyers as megacap tech stocks moved off session lows. Apple (NASDAQ:AAPL) and Amazon.com Inc (NASDAQ:AMZN) were lower, while Meta Platforms Inc (NASDAQ:META), Alphabet (NASDAQ:GOOGL) and Microsoft Corporation (NASDAQ:MSFT) were in the green.

As well as rising rates, consumer stocks continued to reel from increasing geological tensions as Russia’s partial mobilization order has clouded hopes of a resolution to the conflict.

Health care stocks sidestepped the selling, led by Merck&Company Inc (NYSE:MRK), Bristol-Myers Squibb Company (NYSE:BMY), and Eli Lilly and Company (NYSE:LLY) with the latter boosted by an upgrade from UBS.

UBS upgraded Eli Lilly and Company to buy from neutral and lifted its price target on the stock to $363 from $335, citing optimism about the drugmaker’s newly approved type 2 diabetes drug. The drug not only treats type 2 diabetes but was also shown to treat obesity.

Energy stocks were also in the green, underpinned by rising oil prices on fears that the escalation of the war in Ukraine could weigh on supplies.

Valero Energy (NYSE:VLO), Schlumberger (NYSE:SLB) and Marathon Petroleum Corp (NYSE:MPC) were among the biggest gainers in the energy sector.

In other news, Robinhood Markets (NASDAQ:HOOD) reversed gains to turn negative despite reports that the Securities and Exchange Commission won’t ban payment for order flows – a crucial source of revenue for the trading platform.

The weakness in the broader market has pushed stocks further into oversold territory, paving the way for a choppy period ahead.

“Thus, we continue to anticipate a choppy path for stocks in the weeks ahead- noting that after the declines of yesterday and today, stocks for the most part are pressing once again into oversold territory,” Janney Montgomerry Scott said.

Begin trading today! Create an account by completing our form

Privacy Notice

At One Financial Markets we are committed to safeguarding your privacy.

Please see our Privacy Policy for details about what information is collected from you and why it is collected. We do not sell your information or use it other than as described in the Policy.

Please note that it is in our legitimate business interest to send you certain marketing emails from time to time. However, if you would prefer not to receive these you can opt-out by ticking the box below.

Alternatively, you can use the unsubscribe link at the bottom of the Demo account confirmation email or any subsequent emails we send.

By completing the form and downloading the platform you agree with the use of your personal information as detailed in the Policy.

CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 81.6% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

Back to top

Office network
  • London Office
    One Financial Markets 

    1 Finsbury Market
    London
    EC2A 2BN
    United Kingdom


    T:  + 44 ( 0 ) 203 857 2000
    E:  info@ofmarkets.com
  • Dubai Office
    One Financial Markets 
    OT19-39 Central Park Tower
    Dubai International Finance Centre
    Dubai
    United Arab Emirates
     
    T: + 00 971 44 22 888
    E:  info@ofmarkets.com
     

One Financial Markets is the trading name of Axi Financial Services (UK) Ltd, a company registered in England with company number 6050593. Axi Financial Services Ltd is authorised and regulated by the Financial Conduct Authority in the UK (under firm reference number 466201) and the Financial Sector Conduct Authority in South Africa (with FSP number 45784).

The information on this site is not directed at residents of the United States, Belgium, Poland or any particular country outside the UK and is not intended for distribution to, or use by, any person in any country or jurisdiction where such distribution or use would be contrary to local law or regulation.

www.onefinancialmarkets.com is owned and operated by Axi Financial Services (UK) Ltd.

Award winning broker
We have been presented with a number of awards that recognise the quality of our service and dedication to our clients :

Best FSA Regulated Broker
Saudi Money Expo

Best Education Product
Saudi Money Expo

Best Broker - Online Trading
IAIR Awards

Best Institutional Broker
Saudi Money Expo

Best FX Services Broker
CN Forex

Top International
FX Broker 2015

Saudi Money Expo

Broker of the Year
Online Trading – Middle East

IAIR Awards

Best Forex
Customer Service 2018

JFEX Awards

We accept the following payment methods: